Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Gracell Biotechnologies Inc. GRCL

Full chart Compare
Set alert

Price alert · GRCL

All alert types
10.25 +10.25

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

1.49 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2018: -11.2×FY 2019: -5.2×FY 2020: -10.9×FY 2021: -1.1×FY 2022: -0.4×
FY 2018 5y median -5.2× FY 2022
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 1379×FY 2022: 0.0×
FY 2018 5y median 0.0× FY 2022
P/B 0.2×
FY 2018: 286×FY 2019: 2.7×FY 2020: 2.6×FY 2021: 0.3×FY 2022: 0.2×
FY 2018 5y median 2.6× FY 2022
P/FCF -0.1×
FY 2018: -9.3×FY 2019: -3.6×FY 2020: -7.7×FY 2021: -1.4×FY 2022: -0.1×
FY 2018 5y median -3.6× FY 2022
EV/EBITDA 1.9×
FY 2018: -14.0×FY 2019: -3.7×FY 2020: -7.9×FY 2021: 3.0×FY 2022: 1.9×
FY 2018 5y median -3.7× FY 2022
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -3194×FY 2022: 0.0×
FY 2018 5y median 0.0× FY 2022
FCF Yield -1694.0%
FY 2018: -10.7%FY 2019: -27.8%FY 2020: -12.9%FY 2021: -71.6%FY 2022: -1694.0%
FY 2018 5y median -27.8% FY 2022

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -126659.3%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -127289.6%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
ROE -44.2%
FY 2018: -2551.1%FY 2019: -51.8%FY 2020: -24.1%FY 2021: -25.5%FY 2022: -44.2%
FY 2018 5y median -44.2% FY 2022
ROIC -39.9%
FY 2018: -44.3%FY 2019: -35.5%FY 2020: -21.6%FY 2021: -23.3%FY 2022: -39.9%
FY 2018 5y median -35.5% FY 2022
ROA -36.7%
FY 2018: -40.9%FY 2019: -32.1%FY 2020: -20.4%FY 2021: -22.6%FY 2022: -36.7%
FY 2018 5y median -32.1% FY 2022

Growth (YoY)

Revenue -100.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%
FY 2018 FY 2022
Operating Income -34.7%
FY 2018: 0.0%FY 2019: -134.5%FY 2020: -46.3%FY 2021: -116.2%FY 2022: -34.7%
FY 2018 FY 2022
EPS (diluted) -26.7%
FY 2018: 0.0%FY 2019: -117.3%FY 2020: 54.9%FY 2021: -135.2%FY 2022: -26.7%
FY 2018 FY 2022
Free Cash Flow -907.1%
FY 2018: 0.0%FY 2019: -162.0%FY 2020: -44.7%FY 2021: -30.2%FY 2022: -907.1%
FY 2018 FY 2022

Financial Health

Current Ratio 6.8×
FY 2018: 17.2×FY 2019: 18.7×FY 2020: 8.7×FY 2021: 12.2×FY 2022: 6.8×
FY 2018 5y median 12.2× FY 2022
Quick Ratio 6.8×
FY 2018: 16.2×FY 2019: 18.2×FY 2020: 8.7×FY 2021: 12.1×FY 2022: 6.8×
FY 2018 5y median 12.1× FY 2022
Debt / Equity 0.1×
FY 2018: 58.2×FY 2019: 0.5×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×
FY 2018 5y median 0.1× FY 2022
Net Debt / EBITDA 2.3×
FY 2018: -2.2×FY 2019: 1.2×FY 2020: 3.5×FY 2021: 4.3×FY 2022: 2.3×
FY 2018 5y median 2.3× FY 2022
Interest Coverage -92.7×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -99.5×FY 2021: -91.6×FY 2022: -92.7×
FY 2018 5y median -91.6× FY 2022

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31